A randomised phase II trial of carboplatin and gemcitabine +/- vandetanib in first line treatment of advanced urothelial cell cancer patients not suitable to receive cisplatin
| Image |  |
|---|---|
| Description | scientific article published on 25 April 2020 |
| Author/s |
author: Angela Casbard |
| Publication date | April 25, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |